ArticleJournal for immunotherapy of cancer2025

Correction: rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.